questionsmedicales.fr
Cellules
Neurones
Neurofibres
Neurofibres : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Neurofibres : Questions médicales les plus fréquentes",
"headline": "Neurofibres : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Neurofibres : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-06",
"dateModified": "2025-04-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Neurofibres"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Neurones",
"url": "https://questionsmedicales.fr/mesh/D009474",
"about": {
"@type": "MedicalCondition",
"name": "Neurones",
"code": {
"@type": "MedicalCode",
"code": "D009474",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Neurofibres adrénergiques",
"alternateName": "Adrenergic Fibers",
"url": "https://questionsmedicales.fr/mesh/D000320",
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres adrénergiques",
"code": {
"@type": "MedicalCode",
"code": "D000320",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.075"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Neurofibres autonomes postganglionnaires",
"alternateName": "Autonomic Fibers, Postganglionic",
"url": "https://questionsmedicales.fr/mesh/D001338",
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres autonomes postganglionnaires",
"code": {
"@type": "MedicalCode",
"code": "D001338",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.100"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Neurofibres sympathiques postganglionnaires",
"alternateName": "Sympathetic Fibers, Postganglionic",
"url": "https://questionsmedicales.fr/mesh/D017779",
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres sympathiques postganglionnaires",
"code": {
"@type": "MedicalCode",
"code": "D017779",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.100.800"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Axones",
"alternateName": "Axons",
"url": "https://questionsmedicales.fr/mesh/D001369",
"about": {
"@type": "MedicalCondition",
"name": "Axones",
"code": {
"@type": "MedicalCode",
"code": "D001369",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.145"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Segment initial de l'axone",
"alternateName": "Axon Initial Segment",
"url": "https://questionsmedicales.fr/mesh/D000071040",
"about": {
"@type": "MedicalCondition",
"name": "Segment initial de l'axone",
"code": {
"@type": "MedicalCode",
"code": "D000071040",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.145.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cônes de croissance",
"alternateName": "Growth Cones",
"url": "https://questionsmedicales.fr/mesh/D020439",
"about": {
"@type": "MedicalCondition",
"name": "Cônes de croissance",
"code": {
"@type": "MedicalCode",
"code": "D020439",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.145.375"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Fibres moussues de l'hippocampe",
"alternateName": "Mossy Fibers, Hippocampal",
"url": "https://questionsmedicales.fr/mesh/D019599",
"about": {
"@type": "MedicalCondition",
"name": "Fibres moussues de l'hippocampe",
"code": {
"@type": "MedicalCode",
"code": "D019599",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.145.438"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Terminaisons présynaptiques",
"alternateName": "Presynaptic Terminals",
"url": "https://questionsmedicales.fr/mesh/D017729",
"about": {
"@type": "MedicalCondition",
"name": "Terminaisons présynaptiques",
"code": {
"@type": "MedicalCode",
"code": "D017729",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.145.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Collatéraux de Schaffer",
"alternateName": "Schaffer Collaterals",
"url": "https://questionsmedicales.fr/mesh/D000094282",
"about": {
"@type": "MedicalCondition",
"name": "Collatéraux de Schaffer",
"code": {
"@type": "MedicalCode",
"code": "D000094282",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.145.875"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Neurofibres cholinergiques",
"alternateName": "Cholinergic Fibers",
"url": "https://questionsmedicales.fr/mesh/D002799",
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres cholinergiques",
"code": {
"@type": "MedicalCode",
"code": "D002799",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.234"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Neurofibres autonomes préganglionnaires",
"alternateName": "Autonomic Fibers, Preganglionic",
"url": "https://questionsmedicales.fr/mesh/D001339",
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres autonomes préganglionnaires",
"code": {
"@type": "MedicalCode",
"code": "D001339",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.234.060"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Neurofibres parasympathiques postganglionnaires",
"alternateName": "Parasympathetic Fibers, Postganglionic",
"url": "https://questionsmedicales.fr/mesh/D017777",
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres parasympathiques postganglionnaires",
"code": {
"@type": "MedicalCode",
"code": "D017777",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.234.700"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Gaine de myéline",
"alternateName": "Myelin Sheath",
"url": "https://questionsmedicales.fr/mesh/D009186",
"about": {
"@type": "MedicalCondition",
"name": "Gaine de myéline",
"code": {
"@type": "MedicalCode",
"code": "D009186",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.512.560"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Gaine de Schwann",
"alternateName": "Neurilemma",
"url": "https://questionsmedicales.fr/mesh/D009441",
"about": {
"@type": "MedicalCondition",
"name": "Gaine de Schwann",
"code": {
"@type": "MedicalCode",
"code": "D009441",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.512.560.550"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Noeuds de Ranvier",
"alternateName": "Ranvier's Nodes",
"url": "https://questionsmedicales.fr/mesh/D011901",
"about": {
"@type": "MedicalCondition",
"name": "Noeuds de Ranvier",
"code": {
"@type": "MedicalCode",
"code": "D011901",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.512.560.700"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Neurofibres non-myélinisées",
"alternateName": "Nerve Fibers, Unmyelinated",
"url": "https://questionsmedicales.fr/mesh/D036421",
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres non-myélinisées",
"code": {
"@type": "MedicalCode",
"code": "D036421",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.756"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres",
"alternateName": "Nerve Fibers",
"code": {
"@type": "MedicalCode",
"code": "D009412",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Z V Surnina",
"url": "https://questionsmedicales.fr/author/Z%20V%20Surnina",
"affiliation": {
"@type": "Organization",
"name": "Krasnov Research Institute of Eye Diseases, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "S E Avetisov",
"url": "https://questionsmedicales.fr/author/S%20E%20Avetisov",
"affiliation": {
"@type": "Organization",
"name": "Krasnov Research Institute of Eye Diseases, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "Yao-Chuan Chang",
"url": "https://questionsmedicales.fr/author/Yao-Chuan%20Chang",
"affiliation": {
"@type": "Organization",
"name": "Institute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, Manhasset, NY, 11030, USA."
}
},
{
"@type": "Person",
"name": "Stavros Zanos",
"url": "https://questionsmedicales.fr/author/Stavros%20Zanos",
"affiliation": {
"@type": "Organization",
"name": "Institute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, Manhasset, NY, 11030, USA. Electronic address: szanos@northwell.edu."
}
},
{
"@type": "Person",
"name": "Elçin Tunçkol",
"url": "https://questionsmedicales.fr/author/El%C3%A7in%20Tun%C3%A7kol",
"affiliation": {
"@type": "Organization",
"name": "Bernstein Center for Computational Neuroscience Berlin, Humboldt-Universität zu Berlin, Philippstrasse 13, Haus 6, Berlin, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Interactive mirrOring Games wIth sOCial rObot (IOGIOCO): a pilot study on the use of intransitive gestures in a sample of Italian preschool children with autism spectrum disorder.",
"datePublished": "2024-06-28",
"url": "https://questionsmedicales.fr/article/39006819",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpsyt.2024.1356331"
}
},
{
"@type": "ScholarlyArticle",
"name": "Minimising warm ischaemia time during robot-assisted partial nephrectomy. A video-based assessment of tumour excision, kidney reconstruction and intermediate time.",
"datePublished": "2024-06-19",
"url": "https://questionsmedicales.fr/article/38896070",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2340/sju.v59.40397"
}
},
{
"@type": "ScholarlyArticle",
"name": "Membranous urethral length is the single independent predictor of urinary continence recovery at 12 months following Retzius-sparing robot-assisted radical prostatectomy.",
"datePublished": "2024-05-29",
"url": "https://questionsmedicales.fr/article/38809307",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11701-024-01986-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Enhanced recovery after surgery day surgery for MAKO® robotic-arm assisted TKA; better outcome for patients, improved efficiency for hospitals.",
"datePublished": "2024-05-11",
"url": "https://questionsmedicales.fr/article/38800590",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jor.2024.05.013"
}
},
{
"@type": "ScholarlyArticle",
"name": "Safety and Efficacy of a Novel Miniaturized Robotic Assisted Surgery System in Colectomy: A Prospective, Investigational Device Exemption Clinical Study Using the IDEAL Framework.",
"datePublished": "2024-04-23",
"url": "https://questionsmedicales.fr/article/38653496",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/DCR.0000000000003249"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Cellules",
"item": "https://questionsmedicales.fr/mesh/D002477"
},
{
"@type": "ListItem",
"position": 3,
"name": "Neurones",
"item": "https://questionsmedicales.fr/mesh/D009474"
},
{
"@type": "ListItem",
"position": 4,
"name": "Neurofibres",
"item": "https://questionsmedicales.fr/mesh/D009412"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Neurofibres - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Neurofibres",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Neurofibres",
"description": "Comment diagnostiquer une neuropathie ?\nQuels tests pour évaluer les neurofibres ?\nLes IRM sont-elles utiles pour les neurofibres ?\nQuels signes indiquent une atteinte des neurofibres ?\nComment évaluer la conduction nerveuse ?",
"url": "https://questionsmedicales.fr/mesh/D009412?mesh_terms=Robotics&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Neurofibres",
"description": "Quels sont les symptômes d'une neuropathie ?\nComment se manifeste une neuropathie périphérique ?\nLes symptômes varient-ils selon le type de neurofibres ?\nPeut-on avoir des symptômes sans lésions visibles ?\nLes symptômes s'aggravent-ils avec le temps ?",
"url": "https://questionsmedicales.fr/mesh/D009412?mesh_terms=Robotics&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Neurofibres",
"description": "Comment prévenir les neuropathies ?\nL'exercice régulier aide-t-il à prévenir les neuropathies ?\nLes habitudes alimentaires influencent-elles les neurofibres ?\nFumer augmente-t-il le risque de neuropathie ?\nLe stress a-t-il un impact sur les neurofibres ?",
"url": "https://questionsmedicales.fr/mesh/D009412?mesh_terms=Robotics&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Neurofibres",
"description": "Quels traitements existent pour les neuropathies ?\nLes médicaments peuvent-ils soulager la douleur nerveuse ?\nLa physiothérapie aide-t-elle les patients ?\nQuand envisager une intervention chirurgicale ?\nLes traitements sont-ils efficaces pour tous ?",
"url": "https://questionsmedicales.fr/mesh/D009412?mesh_terms=Robotics&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Neurofibres",
"description": "Quelles complications peuvent survenir avec une neuropathie ?\nLa neuropathie peut-elle entraîner des amputations ?\nLes troubles de la marche sont-ils une complication ?\nPeut-on développer une dépression à cause de la neuropathie ?\nLes complications sont-elles réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D009412?mesh_terms=Robotics&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Neurofibres",
"description": "Quels sont les principaux facteurs de risque de neuropathie ?\nL'âge influence-t-il le risque de neuropathie ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe diabète est-il un facteur de risque majeur ?\nLes carences nutritionnelles augmentent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D009412?mesh_terms=Robotics&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une neuropathie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un examen neurologique, des tests électrophysiologiques et des analyses sanguines sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer les neurofibres ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'électromyographie (EMG) et les potentiels évoqués sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les IRM sont-elles utiles pour les neurofibres ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les IRM peuvent visualiser les lésions nerveuses et les anomalies des neurofibres."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une atteinte des neurofibres ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs, des engourdissements ou une faiblesse musculaire peuvent indiquer une atteinte."
}
},
{
"@type": "Question",
"name": "Comment évaluer la conduction nerveuse ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de conduction nerveuse mesurent la vitesse des signaux dans les neurofibres."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une neuropathie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur, picotements, faiblesse musculaire et perte de sensation."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une neuropathie périphérique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par des douleurs, des engourdissements et des réflexes diminués."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de neurofibres ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes dépendent du type de neurofibres affectées (sensitives, motrices)."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans lésions visibles ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes peuvent survenir sans lésions visibles sur les examens d'imagerie."
}
},
{
"@type": "Question",
"name": "Les symptômes s'aggravent-ils avec le temps ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas, les symptômes peuvent s'aggraver progressivement sans traitement."
}
},
{
"@type": "Question",
"name": "Comment prévenir les neuropathies ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un mode de vie sain, contrôler le diabète et éviter les toxines peuvent aider."
}
},
{
"@type": "Question",
"name": "L'exercice régulier aide-t-il à prévenir les neuropathies ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier améliore la circulation sanguine et la santé nerveuse."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles les neurofibres ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée riche en vitamines B peut soutenir la santé nerveuse."
}
},
{
"@type": "Question",
"name": "Fumer augmente-t-il le risque de neuropathie ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut endommager les vaisseaux sanguins et affecter les nerfs."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur les neurofibres ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut exacerber les symptômes nerveux et affecter la santé globale."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les neuropathies ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent médicaments, thérapies physiques et interventions chirurgicales."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils soulager la douleur nerveuse ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des analgésiques et des anticonvulsivants sont souvent prescrits pour soulager la douleur."
}
},
{
"@type": "Question",
"name": "La physiothérapie aide-t-elle les patients ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la physiothérapie peut améliorer la force musculaire et la coordination."
}
},
{
"@type": "Question",
"name": "Quand envisager une intervention chirurgicale ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une chirurgie est envisagée si les symptômes sont graves et ne répondent pas aux traitements conservateurs."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces pour tous ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité des traitements varie selon la cause et la gravité de la neuropathie."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une neuropathie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections, des blessures et des problèmes d'équilibre."
}
},
{
"@type": "Question",
"name": "La neuropathie peut-elle entraîner des amputations ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des lésions nerveuses sévères peuvent augmenter le risque d'amputation, surtout chez les diabétiques."
}
},
{
"@type": "Question",
"name": "Les troubles de la marche sont-ils une complication ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la neuropathie peut affecter la coordination et entraîner des troubles de la marche."
}
},
{
"@type": "Question",
"name": "Peut-on développer une dépression à cause de la neuropathie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la douleur chronique et les limitations fonctionnelles peuvent contribuer à la dépression."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque de neuropathie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le diabète, l'alcoolisme, les infections et certaines maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de neuropathie ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de neuropathie augmente avec l'âge en raison de la dégradation nerveuse."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de neuropathie peuvent augmenter le risque individuel."
}
},
{
"@type": "Question",
"name": "Le diabète est-il un facteur de risque majeur ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète est l'un des principaux facteurs de risque de neuropathie périphérique."
}
},
{
"@type": "Question",
"name": "Les carences nutritionnelles augmentent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des carences en vitamines B et en acide folique peuvent augmenter le risque de neuropathie."
}
}
]
}
]
}
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterized by persistent deficits in social communication, social interaction, and restricted behaviors. The importance of early inte...
We developed a training protocol using the humanoid robot NAO, called IOGIOCO (Interactive mirroring Games wIth sOCial rObot), based on the use of intransitive gestures embedded in naturalistic dialog...
We demonstrated the tolerability of the protocol. We found that one group (n=4, males and 2 females) reached the training level, while another and group (n=6 males) remained at a familiarization level...
While current results will need a Randomized Controlled Trial to be confirmed, the present work sets an important milestone in using social robots for ASD treatment, aimed at impacting social and comm...
Surgical video review is an emerging tool for assessing patient outcomes, especially in complex surgeries such as robot-assisted partial nephrectomy (RAPN). Assessing and measuring warm ischaemia time...
We evaluated 32 surgical video recordings from patients undergoing RAPN and measured WIT, ExcT, RecT and IntT with a stopwatch. Factors such as tumour characteristics and surgeon experience were also ...
We recorded a median WIT of 1,048 s (17 min and 28 s). The median of ExcT, RecT and IntT was 398 s (37.1% of WIT), 518 s (46.7% of WIT) and 180 s (16.2% of WIT), respectively. We found a significant c...
Tumour morphology influences all surgical times, and surgeon experience influences only ExcT. We observed a short RecT during RAPN though at the cost of increased ExcT, and we believe that improving s...
The influence of anatomical parameters on urinary continence (UC) after Retzius-sparing robot-assisted radical prostatectomy (RS-RARP) remains uncharted. Our objective was to evaluate their associatio...
Robotic-assisted Total Knee Arthroplasty (TKA) was designed to improve implant position accuracy by providing surgeons with real-time intra-operative data to tailor the operation to the patient. Propo...
All patients who had undergone unilateral MAKO® ERAS Day Surgery TKA from August 2020 to July 2021 were prospectively followed up and matched to patients who underwent conventional ERAS Day Surgery TK...
42 patients underwent MAKO® ERAS Day surgery TKA and were matched to 42 patients who underwent conventional ERAS Day surgery TKA. The study found that despite the longer surgical duration, LOS was com...
ERAS Day Surgery protocol can significantly reduce the LOS of patient undergoing MAKO® Robotic-arm Assisted TKA, conferring cost savings and making it a valid option for patients....
Robotics has increased rates of minimally invasive surgery, with distinct advantages over open surgery. However, current commercially available robotic platforms have device and system issues that lim...
To demonstrate the safety and efficacy of a novel miniaturized robotic assisted surgery device in colectomy....
Prospective, Investigational Device Exemption clinical study following the idea, development, exploration, assessment, and long-term follow-up (IDEAL) framework (Stage 2b, exploration)....
Three centers with high-volume robotic colorectal cases and surgeons....
Patients scheduled for a right or left colectomy for benign or malignant disease....
Colectomy with the novel miniaturized robotic assisted surgery device....
For safety, intraoperative and device-related adverse events and 30-day morbidity. For efficacy, successful completion of pre-defined procedural steps without conversion....
Thirty patients (13 female, 17 male) were analyzed. The mean age was 59.4 (SD 13.4) years. Seventy percent (n = 21) were overweight/obese and 53.3% (n = 16) had prior abdominal surgery. Forty percent ...
Single arm study, short-term follow-up....
This first clinical study of a novel miniaturized robotic-assisted surgery device along the IDEAL framework demonstrated it was safe and effective. Given this success, further assessment and long-term...
Although a trend of an improved alignment with robotic total hip arthroplasty (THA) over conventional methods has surfaced from recent series, it is unknown whether these results translate into meanin...
Records were extracted from 2016-2019 from the National Inpatient Sample (NIS) database Healthcare Cost and Utilization Project which is the largest in-patient database in the United States. From 367,...
Demographic distributions between robotic and conventional THA groups displayed similar age and sex characteristics. Shorter mean lengths of stay (1.87 days) were seen in robotic THA versus convention...
Evidence has emerged from our results to support more routine adaptation of the robotic option of performing a THA. These can be based on lower local, systemic, and mechanical complications as demonst...
To evaluate the effectiveness of robot-assisted therapy (RAT) followed by activities of daily living (ADL) training in comparison with conventional rehabilitation therapy (CRT) and ADL training in ind...
A single-blind, two-arm, parallel-group, open-level, randomized controlled trial....
A tertiary care teaching hospital in India PARTICIPANTS: Forty-four persons (n=44) with first-ever stroke (in subacute stage) were enrolled from August 2021, to July, 2023....
Participants in the RAT group (n=22) received RAT for 30 minutes, followed by ADL training for 30 minutes. In contrast, participants in the CRT group (n=22) received CRT (30 minutes) followed by ADL t...
Primary outcome: Motor domain score of the Fugl-Meyer Assessment scale for upper extremity (FMA-UE)....
the other domains scores of FMA-UE (UL -sensation, -joint motions, -joint pain); Modified Ashworth Scale (MAS) (spasticity); hand-function (HF) and ADL-domain scores of the stroke impact scale (SIS); ...
Persons who received RAT and ADL training reported significant improvement (p<0.05) in UL motor function [Mean difference (MD)=3.54;(95% confidence interval (CI): 1.28 to 5.79)], UL passive joint moti...
The findings indicate that RAT followed by ADL training is more effective than CRT followed by ADL training in motor improvement, hand functions, ADL, and QOL at 12 weeks....
Minimally invasive extended totally extraperitoneal (eTEP) technique is revolutionising ventral hernia repairs. Robotic-assisted eTEP has been gaining popularity due to better visual clarity and great...
To compare the short- and long-term outcomes between robotic gastrectomy (RG) and laparoscopic gastrectomy (LG) for gastric cancer....
The clinical outcomes of RG over LG have not yet been effectively demonstrated....
This retrospective cohort study included 3,599 patients with gastric cancer who underwent radical gastrectomy at eight high-volume hospitals in China from August 2016 to June 2019. Propensity score ma...
After 1:1 PSM, 1034 pairs of patients were enrolled in a balanced cohort for further analysis. The 3-year DFS in the RG and LG was 83.7% and 83.1% (P=0.745), respectively, and the 3-year overall survi...
For resectable gastric cancer, including advanced cases, RG is a safe approach with comparable 3-year oncological outcomes to LG when performed by experienced surgeons....
Peritoneal carcinomatosis is a particularly rare presentation of prostate cancer. Here we report a rare clinical case of surgically identified peritoneal carcinomatosis at the time of a planned roboti...
A 72-year-old man, with a history of urinary retention managed with tamsulosin, presented to his local urologist. Prostatic urethral lift procedures were performed for symptom management. After a defi...
Our patient, diagnosed with peritoneal carcinomatosis during a planned RALP, highlights the importance of vigilant laparoscopic exam prior to this prostatectomy. Multidisciplinary discussion is crucia...